Analgesics - A Worldwide Market Intelligence Report

Jan 29, 2010, 07:35 ET from Reportlinker

NEW YORK, Jan. 29 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Analgesics - A Worldwide Market Intelligence Report

http://www.reportlinker.com/p0164216/Analgesics---A-Worldwide-Market-Intelligence-Report.html

An aging baby boomer population and subsequent rise in geriatric population, and rising therapeutic benefits of pain treatment drugs (internal) are major factors driving growth in the global analgesics market. Expanding number of surgical procedures, and longer life of patients suffering from chronic illnesses such as cancer and AIDS further contribute to increased demand for analgesics. The market is characterized by the presence of a large number of patent-expired products.

Dynamics of the pain management drugs market witnessed significant changes in recent years. The failure of several drugs, considered initially as promisingly curative including recent unsuccessful COX-2 inhibitors, prompted manufacturers and researchers to undertake more research programs. There is a lucrative market for effective analgesics, which do not cause any adverse side effects.

These and other market data and trends are presented in "Analgesics: A Worldwide Market Intelligence Report" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

ANALGESICS BMR-1016

CONTENTS

1. METHODOLOGY 1

Study Reliability and Reporting Limitations 1

Disclaimers 2

Quantitative Techniques & Reporting Level 3

2. GLOBAL ANALGESICS MARKET OVERVIEW 4

Pain Therapeutic Market 4

Analgesics Market - Offering Immense Potential 4

Liquid Analgesics Register Rapid Growth 4

Neuropathic Pain - Unexplored 5

Ibuprofen Scoring High 5

External Analgesics - In a slump 5

Boom in Demand for Topical Analgesic Patches 5

3. PRODUCT FACTS 6

1. Internal Analgesics 6

Aspirin 6

Acetaminophen 6

Ibuprofen 6

Others (includes combination drugs) 6

2. External Analgesics 6

Combination Analgesics 6

4. MARKET TRENDS 7

Escalating R&D Costs: A Boon or Bane? 7

Cox II Crisis Tarnishes Industry Growth 7

Novel Therapies to Propel Opioid and Non-Opioid Therapies 8

Rx-to-OTC Switch 8

Why Consumers Prefer OTC Drugs? 8

Development of Analgesic Tripeptides 9

5. CORPORATE DEVELOPMENTS 9

Bayer to Acquire Sagmel's OTC Business 9

E5 Pharma Receives Approval from FDA 9

Pharmaceutical Associates Receives Approval from FDA 9

Concord Receives New Drug Approvals 9

Hisamitsu Receives Approval for SALONPAsO 9

Johnson & Johnson Submits NDA to FDA 10

Nycomed and Paladin Inks Joint-Promotion Agreement for Tridural 10

Akela Extends Agreement with Janssen 10

Daiichi and Lead Chemical Receives Approval for LoxoninO Tape 10

Tokio Marine Capital to Acquire Showa Yakuhin Kako 11

Corgenix Collaborates with Randox Laboratories 11

Corgenix Receives EPO Approval for Aspirin Resistance Method 11

IOL to Expand Production Capacity 11

American Oriental Bioengineering Partners with China Aoxing 11

Abraxis Takes Over Shimoda and its Subsidiary Company 11

ProEthic Pharmaceuticals Releases Ibudone for Acute Pain

Management 12

Dr. Reddy's Laboratories Introduces Supanac for Acute Pain

Management 12

PLx Initiates Clinical Trial For Aspirin-PC 12

Ranbaxy Receives Approval from FDA 12

Wockhardt Receives FDA Approval for DPN + APAP 12

Alpharma to Market Flector® Patch in the US 13

Auriga and Mikart Inks Agreement to Market Codein 13

Watson Receives FDA Approval for Oxycodone Hydrochloride and

Ibuprofen 13

Labopharm's Tramadol Receives Approval in Canada 13

Lion Acquires BUFFERIN® Trademark Rights 13

Grunenthal's Extends Licensing Agreement with Ortho-McNeil 14

China Aoxing Pockets LRT 14

Anesiva Inks Joint Venture Agreement Wanbang 14

Beijing Med-Pharm Inks Agreement with Lotus Healthcare 14

LAB International Inks Licensing Agreement with Janssen

Pharmaceutica 14

Three Sixty Pockets Rockford-Montgomery Labs 15

Antares Enters into License and Development Agreement for

Opioid Analgesic 15

Neurodiscovery Receives Approval for NSL-101 Phase II

Clinical Trials 15

Mallinckrodt Introduces Magnacet™ Tablets for Pain Management 15

Wockhardt to Launch New Painkiller 15

Paladin Labs and Labopharm Introduce Tridural™ 15

Shionogi & Co Introduces OxiNorm Powder 0.5% 16

6. MAJOR PLAYERS 16

Bayer Consumer Care (USA) 16

Bristol-Myers Squibb Company (USA) 16

Johnson & Johnson (USA) 16

McNeil Consumer Healthcare (Canada) 17

Novartis International AG (Switzerland) 17

Pfizer Inc. (USA) 17

Reckitt Benckiser Group Plc (UK) 17

Sanofi Aventis (France) 18

Wyeth (USA) 18

Wyeth Consumer Healthcare 18

7. MARKET ANALYTICS 19

8. THE UNITED STATES 27

Pain Statistics in the US 27

Industry Overview 27

Internal Analgesics 28

Cox-2 Drugs in for Some Trouble 28

Switch to OTC Drugs 28

Promotional Strategies for the Internal Analgesics 30

Pediatric Analgesics: The New Kid on the Block 30

External Analgesics 30

Stretching Boundaries 30

Rubs, Patches: Driving the External Analgesics Market 31

Patch Relief Gaining Momentum 32

9. CANADA 33

10. JAPAN 34

11. EUROPE 35

European Pain Management Market 36

Generics Restrain Revenue Growth 36

a. France 39

b. Germany 41

c. The United Kingdom 43

d. Italy 44

e. Spain 46

f. Rest of Europe 48

12. ASIA-PACIFIC 49

The OTC Analgesic Market 49

Comparison of Major Regions for OTC Analgesics Market in

Asia-Pacific - 2004 49

Aspirin - The Chinese Market 49

13. LATIN AMERICA 51

14. REST OF WORLD 52

EXHIBITS

Table 1: Market Shares of Opioid/ Acetaminophen Combination

Products in the Opioid Script Volume

Table 2: Global Analgesics Market by Region for the Period

2007-2015 (Sales in US$ Million)

Table 3: Percentage Breakdown of Global Analgesics Market by

Region for the Years 2008 & 2012

Table 4: Global Internal Analgesics Market by Region for the

Period 2007-2015 (Sales in US$ Million)

Table 5: Percentage Breakdown of Global Internal Analgesics

Market by Region for the Years 2008 & 2012

Table 6: Global Internal Analgesics Market by Segment for the

Period 2007-2015 (Sales in US$ Million)

Table 7: Percentage Breakdown of Global Internal Analgesics

Market by Segment for the Years 2008 & 2012

Table 8: Global Aspirin Market by Region for the Period

2007-2015 (Sales in US$ Million)

Table 9: Percentage Breakdown of Global Aspirin Market by

Region for the Years 2008 & 2012

Table 10: Global Acetaminophen Market by Region for the

Period 2007-2015 (Sales in US$ Million)

Table 11: Percentage Breakdown of Global Acetaminophen Market

by Region for the Years 2008 & 2012

Table 12: Global Ibuprofen Market by Region for the Period

2007-2015 (Sales in US$ Million)

Table 13: Percentage Breakdown of Global Ibuprofen Market by

Region for the Years 2008 & 2012

Table 14: Global Other Internal Analgesics Market by Region

for the Period 2007-2015 (Sales in US$ Million)

Table 15: Percentage Breakdown of Global Other Internal

Analgesics Market by Region for the Years 2008 & 2012

Table 16: Global External Analgesics by Region for the Period

2007-2015 (Sales in US$ Million)

Table 17: Percentage Breakdown of Global External Analgesics

by Region for the Years 2008 & 2012

Table 18: Market Shares of Top Ten Brands in the US Internal

Tablet Analgesics Market - 2007

Table 19: Market Shares of Top Ten Brands in the US Internal

Liquid Analgesics Market - 2007

Table 20: Market Shares of Retail Distribution Channels for

Internal Analgesics in the US - 2008E

Table 21: Market Shares of Retail Distribution Channels for

Internal Liquid Analgesics in the US - 2008E

Table 22: Market Shares of Top Ten Brands in the US External

Analgesics Market - 2007

Table 23: Market Shares of Retail Distribution Channels for

External Analgesics in the US - 2008E

Table 24: Analgesics Market by Segment in US: 2007-2015 (Sales

in US$ Million)

Table 25: Percentage Breakdown of Analgesics Market by Segment

in US for the Years 2008 & 2012

Table 26: Analgesics Market by Segment in Canada: 2007-2015

(Sales in US$ Million)

Table 27: Percentage Breakdown of Analgesics Market by Segment

in Canada for the Years 2008 & 2012

Table 28: Market Shares of Leading OTC Analgesics

Manufacturers in Japan - 2005

Table 29: Analgesics Market by Segment in Japan: 2007-2015

(Sales in US$ Million)

Table 30: Percentage Breakdown of Analgesics Market by Segment

in Japan for the Years 2008 & 2012

Table 31: Market Shares of Popular Brands in the European

Pain & Inflammation Medication Market - 2004

Table 32: Analgesics Market by Region in Europe: 2007-2015

(Sales in US$ Million)

Table 33: Percentage Breakdown of Analgesics Market by Region

in Europe for the Years 2008 & 2012

Table 34: Analgesics Market by Segment in Europe: 2007-2015

(Sales in US$ Million)

Table 35: Percentage Breakdown of Analgesics Market by Segment

in Europe for the Years 2008 & 2012

Table 36: Market Shares of Leading Analgesics Manufacturers in

France - 2005

Table 37: Analgesics Market by Segment in France: 2007-2015

(Sales in US$ Million)

Table 38: Percentage Breakdown of Analgesics Market by Segment

in France for the Years 2008 & 2012

Table 39: Market Shares of Leading Analgesics Manufacturers in

Germany - 2005

Table 40: Analgesics Market by Segment in Germany: 2007-2015

(Sales in US$ Million)

Table 41: Percentage Breakdown of Analgesics Market by Segment

in Germany for the Years 2008 & 2012

Table 42: Market Shares of Leading Analgesics Manufacturers in

the UK - 2005

Table 43: Analgesics Market by Segment in UK: 2007-2015 (Sales

in US$ Million)

Table 44: Percentage Breakdown of Analgesics Market by Segment

in UK for the Years 2008 & 2012

Table 45: Market Shares of Leading Analgesics Manufacturers in

Italy - 2005

Table 46: Analgesics Market by Segment in Italy: 2007-2015

(Sales in US$ Million)

Table 47: Percentage Breakdown of Analgesics Market by Segment

in Italy for the Years 2008 & 2012

Table 48: Market Shares of Leading Analgesics Manufacturers in

Spain - 2005

Table 49: Analgesics Market by Segment in Spain: 2007-2015

(Sales in US$ Million)

Table 50: Percentage Breakdown of Analgesics Market by Segment

in Spain for the Years 2008 & 2012

Table 51: Analgesics Market by Segment in Rest of Europe:

2007-2015 (Sales in US$ Million)

Table 52: Percentage Breakdown of Analgesics Market by Segment

in Rest of Europe for the Years 2008 & 2012

Table 53: Analgesics Market by Segment in Asia-Pacific:

2007-2015 (Sales in US$ Million)

Table 54: Percentage Breakdown of Analgesics Market by Segment

in Asia- Pacific for the Years 2008 & 2012

Table 55: Analgesics Market by Segment in Latin America:

2007-2015 (Sales in US$ Million)

Table 56: Percentage Breakdown of Analgesics Market by Segment

in Latin America for the Years 2008 & 2012

Table 57: Analgesics Market by Segment in Rest of World:

2007-2015 (Sales in US$ Million)

Table 58: Percentage Breakdown of Analgesics Market by Segment

in Rest of World for the Years 2008 & 2012

COMPANIES PROFILED

To order this report:

: Analgesics - A Worldwide Market Intelligence Report

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg

Reportlinker

Email: nbo@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626


SOURCE Reportlinker



RELATED LINKS

http://www.reportlinker.com